In vitro and in vivo evaluation of the combination of cisplatin and its analogue carboplatin for platinum dose intensification in ovarian carcinoma
- 15 May 1993
- Vol. 71 (10) , 3082-3090
- https://doi.org/10.1002/1097-0142(19930515)71:10<3082::aid-cncr2820711031>3.0.co;2-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Combining cisplatin and carboplatin complementary or contradictory?Annals of Oncology, 1991
- Follicular lymphoma: A model of lymphoid tumor progression in manAnnals of Oncology, 1991
- Cisplatin/carboplatin cross-resistance in ovarian cancerBritish Journal of Cancer, 1989
- In vitro evaluation of cisplatin interaction with doxorubicin or 4-hydroperoxycyclophosphamide against human gynecologic cancer cell linesCancer Chemotherapy and Pharmacology, 1989
- Cytotoxicity of Cisplatin and Carboplatin Used Alone and in Combination with the Other Anticancer Drugs in the Mouse Embryo C3H10T½ Cell LineChemotherapy, 1988
- Klonieren von soliden TumorenPublished by Springer Nature ,1987
- Ovarian trials at the Royal MarsdenCancer Treatment Reviews, 1985
- USE OF HIGH DOSE CIS-DICHLORODIAMMINE PLATINUM (II) (NSC-119875)+ FOLLOWING FAILURE ON PREVIOUS CHEMOTHERAPY FOR ADVANCED CARCINOMA OF THE OVARYBJOG: An International Journal of Obstetrics and Gynaecology, 1981
- High-dose platinum for the treatment of refractory ovarian cancerGynecologic Oncology, 1981
- Criteria for Analyzing Interactions between Biologically Active AgentsAdvances in Cancer Research, 1981